Clinical Data Science in Adaptive Trial Designs
The traditional, static clinical trial is being replaced in 2026 by Adaptive Trial Designs powered by real-time analytics.
These trials leverage accumulating results during the study to adapt the course of the trial—such as adjusting dosage levels or sample sizes—without compromising integrity. Medidata and other major platforms now offer "Clinical Data Studios" where integrated data from eConsent, sensors, and EHRs are reviewed and reconciled using AI. This flexibility allows sponsors to pivot quickly based on emerging data, significantly reducing the risk of trial failure and accelerating the delivery of personalized medicines.
1 View